Compare NEULAND LABS with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs JUBILANT PHARMOVA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS JUBILANT PHARMOVA NEULAND LABS/
JUBILANT PHARMOVA
 
P/E (TTM) x 48.1 14.7 326.7% View Chart
P/BV x 3.6 2.8 132.3% View Chart
Dividend Yield % 0.1 0.5 18.3%  

Financials

 NEULAND LABS   JUBILANT PHARMOVA
EQUITY SHARE DATA
    NEULAND LABS
Mar-20
JUBILANT PHARMOVA
Mar-19
NEULAND LABS/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs754898 83.9%   
Low Rs247618 40.0%   
Sales per share (Unadj.) Rs594.5572.0 103.9%  
Earnings per share (Unadj.) Rs12.636.2 34.9%  
Cash flow per share (Unadj.) Rs37.059.5 62.2%  
Dividends per share (Unadj.) Rs2.004.50 44.4%  
Dividend yield (eoy) %0.40.6 67.3%  
Book value per share (Unadj.) Rs553.4301.9 183.3%  
Shares outstanding (eoy) m12.83159.28 8.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.3 63.5%   
Avg P/E ratio x39.620.9 189.4%  
P/CF ratio (eoy) x13.512.7 106.2%  
Price / Book Value ratio x0.92.5 36.0%  
Dividend payout %15.812.4 127.4%   
Avg Mkt Cap Rs m6,421120,694 5.3%   
No. of employees `0001.32.4 53.6%   
Total wages/salary Rs m1,23619,260 6.4%   
Avg. sales/employee Rs Th5,949.438,120.6 15.6%   
Avg. wages/employee Rs Th963.88,058.4 12.0%   
Avg. net profit/employee Rs Th126.42,414.3 5.2%   
INCOME DATA
Net Sales Rs m7,62791,108 8.4%  
Other income Rs m39357 10.9%   
Total revenues Rs m7,66691,466 8.4%   
Gross profit Rs m1,01917,390 5.9%  
Depreciation Rs m3133,709 8.4%   
Interest Rs m2162,198 9.8%   
Profit before tax Rs m52911,840 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m3673,268 11.2%   
Profit after tax Rs m1625,770 2.8%  
Gross profit margin %13.419.1 70.0%  
Effective tax rate %69.427.6 251.3%   
Net profit margin %2.16.3 33.6%  
BALANCE SHEET DATA
Current assets Rs m5,15245,848 11.2%   
Current liabilities Rs m3,57620,897 17.1%   
Net working cap to sales %20.727.4 75.4%  
Current ratio x1.42.2 65.7%  
Inventory Days Days10557 185.0%  
Debtors Days Days9151 178.4%  
Net fixed assets Rs m3,96965,498 6.1%   
Share capital Rs m129159 81.0%   
"Free" reserves Rs m6,97147,930 14.5%   
Net worth Rs m7,10048,089 14.8%   
Long term debt Rs m77442,429 1.8%   
Total assets Rs m12,310114,685 10.7%  
Interest coverage x3.56.4 54.1%   
Debt to equity ratio x0.10.9 12.4%  
Sales to assets ratio x0.60.8 78.0%   
Return on assets %3.16.9 44.2%  
Return on equity %2.312.0 19.0%  
Return on capital %9.512.4 76.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,18712,422 41.8%   
Fx outflow Rs m1,59317,227 9.2%   
Net fx Rs m3,594-4,805 -74.8%   
CASH FLOW
From Operations Rs m57311,215 5.1%  
From Investments Rs m-487-10,118 4.8%  
From Financial Activity Rs m-556,574 -0.8%  
Net Cashflow Rs m337,612 0.4%  

Share Holding

Indian Promoters % 36.3 45.6 79.5%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 63.7 8.7 732.5%  
FIIs % 0.0 21.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 63.7 21.1 302.0%  
Shareholders   12,705 23,815 53.3%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA  

Compare NEULAND LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NEULAND LABS SHARE PRICE


May 17, 2021 (Close)

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NEULAND LABS 8-QTR ANALYSIS

COMPARE NEULAND LABS WITH

MARKET STATS